1Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction:A report of the American College of Cardiology/American Heart Association Task Force on Practice (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction)[J].J Am Coll Cardiol,2004,44(3):E1-E211.
2Ryan TJ,Antman EM,Brooks NH,et al.1999 update:ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary and Recommendations:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)[J].Circulation,1999,100(9):1016-1030.
3Eisenberg MJ,Topal EJ.Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction[J].Arch Intern Med,1996,156(14):1506-1510.
4Patrono C,Bachmann F,Baigent C,et al.ESC expert consensus document on the use of antiplatelet agents:a report by the task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology[J].Eur Heart J,2004,25(2):166-181.
5Hsia J,Hamilton WP,Kleiman N,et al.A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction[J].N Engl J Med,1990,323(21):1433-1437.
7The TIMI Study Group.Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction:results of the Thrombolysis In Myocardial Infarction (TIMI) phase Ⅱ trial[J].N Engl J Med,1989,320(10):618-627.
8Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico (GISSI).GISSI-3:effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction[J].Lancet,1994,343(8906):1115-1122.
9Ambrosioni E,Borghi C,Magnani B,et al.The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction[J].N Engl J Med,1995,332(2):80-85.
10The Scandinavian Simvastatin Survival Study (4S).Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease[J].Lancet,1994,344(8934):1383-1389.
6Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).J Am Coll Cardiol,2004,44:671-719.
7Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA,2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients with Unstable Angina).J Am Coll Cardiol,2002,40:1366-1374.
8Van de Werf F,Ardissino D,Betriu A,et al.Management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J,2003,24:28-66.
9Hasdai D,Behar S,Wallentin L,et al.A prospective survey of the characteristics,treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin,the Euro Heart Survey of Acute Coronary Syndromes.Eur Heart J,2002,23:1190-1201.
10Rogers WJ,Bowlby LJ,Chandra NC,et al.Treatment of myocardial infarction in the United States (1990-1993),observations from the national registry of myocardial infarction.Circulation,1994,90:2103-2114.
